Treating IgA Nephropathy - Who, When and How?.
Feehally
John
J
Department of Nephrology, Leicester General Hospital, Leicester, UK.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000627:therapeutic use; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007165:Immunosuppression Therapy; D011239:Prednisolone / Q000008:administration & dosage; D011507:Proteinuria / Q000209:etiology / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000806:Angiotensin-Converting Enzyme Inhibitors; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine